1Duance TD. Clinical Ophthalmology New York, San Francisco. London: Harper&Row, 1998, 3: 2107～2100.
2King H, Aubert R E. Herman WH Global burden of diabetes 1995 - 2025 prevalence numerical estimates and projections. DiabetesCare, 1998, 21: 1414～1431.
4Ii W, Zhou Q, Qin M, et al. Reduced absolute rate of myoinositol synthesis of cultural bovine retinal capillary pericyas in high glucose. Exp- eye- res, 1991, 52: 569～573.
6Masakazu M, et al. The effect of high gloucose and aldose reduct as in hibitor on myo - inositol uptube in cultural bvine pericyte. Diabetes, 1998, 47 (suppl 1): A379～385.
7Neuenchwander H, et al. Dose- dependent reduction of retinal vessel changes associated with diabetic retinopathy in gluctosefed dogs by the aldose redutase inhibitor. M 79175 JOcul PharmacolTher, 1997, 13: 517～523.
9Vlassara H, et al. Pathogenic effects of advanced glycosylation: biochemical biologic and clinical implications for diabetes and aging. Lab Invest, 1994, 70: 138～140.
10Brownlee M. Glycation produets and the pathogenesis of diabeticcomplications. Diabetes Care, 1992, 15 (12): 1835～1840.
6[2]Negoescu A, Lorimier P, Labat-Moleur F,et al. TUNEL improvement and evaluation of the method for in situ apoptotic cellidentification[J]. Miochmica,1997,2:12.
7[3]Brusch W, Paffe S, Puta B,et al. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats[J]. Carcinogenesis,1990,11:847.
8[4]Zhivotovsky B, Cedervall B, Jiang S,et al. Involvement of Ca2+ in the formation of high molecular weight DNA fragments in thymocyte apoptosis[J]. Biochem Biophys Res Commun,1994,202:120.
9[5]Ansari B. In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states[J]. J Pathol,1993,170:1.
10[6]Kerr JFR, Winterford CM, Harmon BY. Apoptosis: its significance in cancer and and cancer therapy[J]. Cancer,1994,73:2013.
